The molecular combinations involved in creating new treatments are vast, so Nvidia is customizing its technology to address ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they’re ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

By Kamal Choudhury Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has ...

By Ludwig Burger FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research ...

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...

Now, it’s worth noting Stock Advisor’s total average return is 1,018% — a market-crushing outperformance compared to 194 % ...

Artificial Intelligence (“AI”) has been utilized by innovative companies across the array of industry spaces, but its impact on biotech (and human health in general) could become the most significant ...